Table 4.
|
PP |
Paliperidone ER |
PP placebo |
Paliperidone ER placebo |
---|---|---|---|---|
(n = 193) | (n = 104) | (n = 192) | (n = 101) | |
Subjects with events, n (%) |
32 (17) |
23 (22) |
90 (47) |
52 (51) |
Hazard ratio (95% CI)a | 2.52 (1.46 to 4.35) | 2.25 (1.59 to 3.18) |
aHazard ratios reflect paliperidone ER/PP for active treatments and placebo treatments, respectively. CI confidence interval, ER extended release, PP paliperidone palmitate.